Ratiopharm

MOMETASONE

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  (8xi,11beta,16alpha)-9,21-Dichlor-11,17-dihydroxy-16-methylpregna-1,4-dien-3,20-dion;(8xi,11beta,16alpha)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione;(9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one;pregna-1,4-diene-3,20-dione, 9,21-dichloro-11,17-dihydroxy-16-methyl-, (8xi,11beta,16alpha)-;(11beta,16alpha)-9,21-dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione;(11beta,16alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate;

• CAS NO :

  105102-22-5

• EC NO :

• Molecular Formula :

  C₂₇H₃₀Cl₂O₆

• Molecular Weight :

  521.4295

• Main Specifications :

• InChI :

  InChI=1/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1

• Molecular Structure :